167 related articles for article (PubMed ID: 30828862)
61. Lipoamide Inhibits NF1 Deficiency-induced Epithelial-Mesenchymal Transition in Murine Schwann Cells.
Zhang Y; Zhou R; Qu Y; Shu M; Guo S; Bai Z
Arch Med Res; 2017 Aug; 48(6):498-505. PubMed ID: 29198560
[TBL] [Abstract][Full Text] [Related]
62. Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.
Oliveira LB; Geller M; Cunha KS; Santos A; Bernacchi A; Rubenstein AE; Takirambudde S; Mezitis S; de Almeida Ito Brum C; Darrigo LG; Ribeiro MG
Heliyon; 2021 Mar; 7(3):e06518. PubMed ID: 33817379
[TBL] [Abstract][Full Text] [Related]
63. Anemic nevus in neurofibromatosis type 1.
Tadini G; Brena M; Pezzani L; Gelmetti C; Santagada F; Boldrini MP
Dermatology; 2013; 226(2):115-8. PubMed ID: 23713063
[TBL] [Abstract][Full Text] [Related]
64. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.
Woodruff JM
Am J Med Genet; 1999 Mar; 89(1):23-30. PubMed ID: 10469433
[TBL] [Abstract][Full Text] [Related]
65. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
Yang FC; Chen S; Clegg T; Li X; Morgan T; Estwick SA; Yuan J; Khalaf W; Burgin S; Travers J; Parada LF; Ingram DA; Clapp DW
Hum Mol Genet; 2006 Aug; 15(16):2421-37. PubMed ID: 16835260
[TBL] [Abstract][Full Text] [Related]
66. A case of microcystic lymphatic malformation successfully treated with topical sirolimus.
Çalışkan E; Altunel CT; Özkan CK; Tunca M
Dermatol Ther; 2018 Sep; 31(5):e12673. PubMed ID: 30133999
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of skin viscoelasticity in type 1 neurofibromatosis patients.
Mimoun N; Razzouq N; Wolkenstein P; Moreno JC; Marty JP; Lantieri L; Astier A; Paul M
Skin Pharmacol Physiol; 2006; 19(1):22-7. PubMed ID: 16247246
[TBL] [Abstract][Full Text] [Related]
68. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
69. Palatal neurofibroma associated with localized periodontitis.
Powell CA; Stanley CM; Bannister SR; McDonnell HT; Moritz AJ; Deas DE
J Periodontol; 2006 Feb; 77(2):310-5. PubMed ID: 16460259
[TBL] [Abstract][Full Text] [Related]
70. [Neurofibroma of the penis in the course of Recklinghausen's disease].
Romaszewski W; Beer-Jackiewicz O
Pol Przegl Chir; 1969 Nov; 41(11):Suppl 11a:1651. PubMed ID: 4983536
[No Abstract] [Full Text] [Related]
71. Cutaneous epithelioid melanocytic neurofibroma arising in a patient with neurofibromatosis-1.
Novoa RA; Kovarik CL; Low DW; Argenyi Z
J Cutan Pathol; 2014 May; 41(5):457-61. PubMed ID: 24472086
[TBL] [Abstract][Full Text] [Related]
72. Neurofibromatosis: challenges for applied cellular and molecular biology.
Riccardi VM
Lab Invest; 1988 Dec; 59(6):726-8. PubMed ID: 3143861
[No Abstract] [Full Text] [Related]
73. Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1.
Fadda MT; Verdino G; Mustazza MC; Bartoli D; Iannetti G
Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):553-7. PubMed ID: 18329107
[TBL] [Abstract][Full Text] [Related]
74. Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials.
Cannon A; Pichard DC; Wolters PL; Adsit S; Erickson G; Lessing AJ; Li P; Narmore W; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR;
Neurology; 2021 Aug; 97(7 Suppl 1):S15-S24. PubMed ID: 34230202
[TBL] [Abstract][Full Text] [Related]
75. Bilateral cervicomediastinal neurofibroma originating from the vagal nerve in a patient with von Recklinghausen's disease: report of a case.
Shintani Y; Ohta M; Hazama K; Minami M; Okumura M; Hirabayashi H; Matsuda H
Surg Today; 2002; 32(12):1068-71. PubMed ID: 12541024
[TBL] [Abstract][Full Text] [Related]
76. Segmental neurofibromatosis.
Schultz ES; Kaufmann D; Tinschert S; Schell H; von den Driesch P; Schuler G
Dermatology; 2002; 204(4):296-7. PubMed ID: 12077526
[TBL] [Abstract][Full Text] [Related]
77. [Unilateral facial and cerebral hyperplasia associated with neurofibromatosis type 1. Report of four patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Burgueno M; Martin-Perez M; Palencia R; Garcia-Segura JM; Valero C
Rev Neurol; 2006 Sep 16-30; 43(6):346-52. PubMed ID: 16981165
[TBL] [Abstract][Full Text] [Related]
78. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
[TBL] [Abstract][Full Text] [Related]
79. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
[TBL] [Abstract][Full Text] [Related]
80. Neurofibromatosis type 1: Factors associated with flare-ups of cutaneous neurofibromas at puberty.
Skayem C; Fertitta L; Diaz E; Jannic A; Ferkal S; Ravaud P; Tran VT; Ezzedine K; Wolkenstein P
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e158-e159. PubMed ID: 36226401
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
